EXEL will likely be sold. The way Cabo is being developed will financially weaken the company and create vulnerability. Roche simply needs to wait, as it's obvious EXEL will need cash. MM believes he's creating value but his approach to finances has been dismal. Likely little stomach left for a dilution - I expect the company is being prepared for sale. Ironically, it may have had more value without the additional Cabo trials. Bad poker playing by MM. Hope for a COMET surprise.
Intelligent life on Planet EXEL. I knew it was out there somewhere ;-)
Isn;' it amazing how TA so often times PREDICT the "news" (i.e. bearish setup then "we need to dilute more" bombshell)? After over two decades of doing this, is still amazes me! EXEL = DEAD $$$$$$$. Put a fork in her until mid 2014 at the earliest. They may need to do a reverse split if they keep issuing shares at the clip they are doing it. Already 120 MILLION shares OS. Ouch.